YTHDF1’s Regulatory Involvement in Breast Cancer Prognosis, Immunity, and the ceRNA Network
International Journal of Molecular Sciences · 04.02.2024 · 25 (3) · 1879
DOI: 10.3390/ijms25031879 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.02.2024. Verfasst von Wenting Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, Medical College, Nanchang University, 461 Bayi Road, Nanchang 330006, China. Hauptthemen laut MEDLINE: MicroRNAs, RNA-Binding Proteins, Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Project of Jiangxi Provincial Natural Science Foundation, Key laboratory of functional and clinical translational medicine, Fujian province university.
Abstract (Originalsprache)
YTH N6-methyladenosine RNA binding protein 1 (YTHDF1), an m6A reader, has a role in the development and progression of breast cancer as well as the immunological microenvironment. The networks of competing endogenous RNA in cancer have received much attention in research. In tumor gene therapy, the regulatory networks of m6A and competing endogenous RNA are increasingly emerging as a new route. We evaluated the relationship between the YTHDF1 expression, overall survival, and clinicopathology of breast cancer using TCGA, PrognoScan, and other datasets. We used Western blot to demonstrate that YTHDF1 is substantially expressed in breast cancer tissues. Furthermore, we explored YTHDF1′s functions in the tumor mutational burden, microsatellite instability, and tumor microenvironment. Our findings indicate that YTHDF1 is a critical component of the m6A regulatory proteins in breast cancer and may have a particular function in the immunological microenvironment. Crucially, we investigated the relationship between YTHDF1 and the associated competitive endogenous RNA regulatory networks, innovatively creating three such networks (Dehydrogenase/Reductase 4-Antisense RNA 1-miR-378g-YTHDF1, HLA Complex Group 9-miR-378g-YTHDF1, Taurine Up-regulated 1-miR-378g-YTHDF1). Furthermore, we showed that miR-378g could inhibit the expression of YTHDF1, and that miR-378g/YTHDF1 could impact MDA-MB-231 proliferation. We speculate that YTHDF1 may serve as a biomarker for poor prognosis and differential diagnosis, impact the growth of breast cancer cells via the ceRNA network axis, and be a target for immunotherapy against breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, Medical College, Nanchang University, 461 Bayi Road, Nanchang 330006, China.
- Second Clinical Medical College, Nanchang University, Nanchang 330006, China.
- First Clinical Medical College, Nanchang University, Nanchang 330006, China.
- Queen Mary School, Nanchang University, Nanchang 330006, China.
- College of Pharmacy, Nanchang University, Nanchang 330006, China.
- Key Laboratory of Functional and Clinical Translational Medicine, Xiamen Medical College, Fujian Province University, Xiamen 361023, China.
ORCID-Profile: Lixia Xiong
Förderung
- National Natural Science Foundation of China
- Key Project of Jiangxi Provincial Natural Science Foundation
- Key laboratory of functional and clinical translational medicine, Fujian province university
- the college students innovation training program of Nanchang University
- National natural science foundation of Jiangxi province
- college students innovation training program of Nanchang University
Zitieren
APA
Luo, W., Zhou, Y., Wang, J., Wang, K., Lin, Q., Li, Y., Xie, Y., Li, M., Wang, J., & Xiong, L. (2024). YTHDF1’s Regulatory Involvement in Breast Cancer Prognosis, Immunity, and the ceRNA Network. International Journal of Molecular Sciences, 25(3), 1879. https://doi.org/10.3390/ijms25031879
Vancouver
Luo W, Zhou Y, Wang J, Wang K, Lin Q, Li Y, et al. YTHDF1’s Regulatory Involvement in Breast Cancer Prognosis, Immunity, and the ceRNA Network. International Journal of Molecular Sciences. 2024;25(3):1879. doi:10.3390/ijms25031879
BibTeX
@article{Luo2024,
author = {Luo, Wenting and Zhou, Youjia and Wang, Jiayang and Wang, Keqin and Lin, Qing and Li, Yuqiu and Xie, Yujie and Li, Miao and Wang, Jie and Xiong, Lixia},
title = {YTHDF1’s Regulatory Involvement in Breast Cancer Prognosis, Immunity, and the ceRNA Network},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {3},
pages = {1879},
doi = {10.3390/ijms25031879}
}
EUVIMED